Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 3 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
PubMed for Bookshelf ID: 5428954
6 results
Results by year
Filters applied: . Clear all
Page 1
Lecanemab for Alzheimer's disease: tempering hype and hope.
Lancet. 2022 Dec 3;400(10367):1899. doi: 10.1016/S0140-6736(22)02480-1.
Lancet. 2022.
PMID: 36463893
No abstract available.
Lecanemab in Early Alzheimer's Disease.
van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T.
van Dyck CH, et al.
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
N Engl J Med. 2023.
PMID: 36449413
Clinical Trial.
Item in Clipboard
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL.
Swanson CJ, et al.
Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8.
Alzheimers Res Ther. 2021.
PMID: 33865446
Free PMC article.
Clinical Trial.
Item in Clipboard
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A.
Sevigny J, et al.
Nature. 2016 Sep 1;537(7618):50-6. doi: 10.1038/nature19323.
Nature. 2016.
PMID: 27582220
Updated.
Item in Clipboard
Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody.
Logovinsky V, Satlin A, Lai R, Swanson C, Kaplow J, Osswald G, Basun H, Lannfelt L.
Logovinsky V, et al.
Alzheimers Res Ther. 2016 Apr 6;8(1):14. doi: 10.1186/s13195-016-0181-2.
Alzheimers Res Ther. 2016.
PMID: 27048170
Free PMC article.
Clinical Trial.
Item in Clipboard
The amyloid hypothesis of Alzheimer's disease at 25 years.
Selkoe DJ, Hardy J.
Selkoe DJ, et al.
EMBO Mol Med. 2016 Jun 1;8(6):595-608. doi: 10.15252/emmm.201606210. Print 2016 Jun.
EMBO Mol Med. 2016.
PMID: 27025652
Free PMC article.
Review.
Item in Clipboard
Cite
Cite